Philip Lee
Algemeen Directeur bij GeneFab LLC
Vermogen: 261 262 $ op 30-04-2024
Actieve functies van Philip Lee
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
GeneFab LLC
 GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Algemeen Directeur | 01-08-2023 | - |
Loopbaan van Philip Lee
Eerdere bekende functies van Philip Lee
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SENTI BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 | 07-08-2023 |
| Oprichter | 01-01-2016 | 07-08-2023 | |
| President | 01-01-2016 | 01-01-2018 | |
| Treasurer | 01-01-2016 | 01-01-2020 | |
| MERCK KGAA | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 | 01-11-2014 |
| Corporate Officer/Principal | 01-11-2014 | 01-05-2016 | |
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 | 01-01-2014 |
| Corporate Officer/Principal | 01-01-2014 | 01-01-2016 | |
Cellasic Corp.
 Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Algemeen Directeur | 01-09-2004 | 01-04-2012 |
| Oprichter | 01-09-2004 | 01-04-2012 | |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Directeur/Bestuurslid | 01-07-2016 | 01-02-2018 |
| Operationeel Directeur | 01-02-2018 | 01-01-2021 | |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2021 | - | |
| Oprichter | 01-01-2016 | - | |
| President | 01-07-2016 | 01-02-2018 | |
| Treasurer | 01-02-2018 | 01-11-2020 |
Opleiding van Philip Lee
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 9 |
| Duitsland | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
| President | 2 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
Cellasic Corp.
Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Technology Services |
GeneFab LLC
GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Health Technology |
- Beurs
- Insiders
- Philip Lee
- Ervaring
